Advertisement
Advertisement

ATRC

ATRC logo

AtriCure, Inc.

39.20
USD
Sponsored
-0.36
-0.90%
Jan 02, 11:57 UTC -5
Open

ATRC Earnings Reports

Positive Surprise Ratio

ATRC beat 30 of 40 last estimates.

75%

Next Report

Date of Next Report
Feb 10, 2026
Estimate for Q4 25 (Revenue/ EPS)
$142.05M
/
-$0.09
Implied change from Q3 25 (Revenue/ EPS)
+5.80%
/
+800.00%
Implied change from Q4 24 (Revenue/ EPS)
+14.30%
/
+12.50%

AtriCure, Inc. earnings per share and revenue

On Oct 29, 2025, ATRC reported earnings of -0.01 USD per share (EPS) for Q3 25, beating the estimate of -0.11 USD, resulting in a 91.46% surprise. Revenue reached 134.27 million, compared to an expected 133.88 million, with a 0.29% difference. The market reacted with a -3.81% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 11 analysts forecast an EPS of -0.09 USD, with revenue projected to reach 142.05 million USD, implying an increase of 800.00% EPS, and increase of 5.80% in Revenue from the last quarter.
FAQ
For Q3 2025, AtriCure, Inc. reported EPS of -$0.01, beating estimates by 91.46%, and revenue of $134.27M, 0.29% above expectations.
The stock price moved down -3.81%, changed from $35.44 before the earnings release to $34.09 the day after.
The next earning report is scheduled for Feb 10, 2026.
Based on 11 analysts, AtriCure, Inc. is expected to report EPS of -$0.09 and revenue of $142.05M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement